Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07910656Completed
Randomised, open-label trial in gastroesophageal reflux disease (GERD) (2 arms), sponsored by University of Medicine and Pharmacy of Ho Chi Minh City. Primary endpoint: Gastroesophageal Reflux Disease Questionnaire Score at 4 weeks. Started Mar 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07910656.